SCHEMBL5157523

SCHEMBL5157523

O=[N+]([O-])c1cc(Cl)ccc1I

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.59
TSHR P16473 1/20 0.59
VCAM1 P19320 1/20 0.55
PARP1 P09874 1/20 0.53
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
PDE7A Q13946 7/20 0.49
PDE7B Q9NP56 4/20 0.49
KIF18A Q8NI77 1/20 0.47
PDE4B Q07343 1/20 0.46
PDE4D Q08499 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
KCNMA1 Q12791 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31090891 1.00 MAPK1 (0.59) MAPK1TSHRVCAM1PARP1ALDH1A1
SCHEMBL2766183 0.83 MAPK1 (0.64) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL1524058 0.80 MAPK1 (0.72) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL9641099 0.80 MAPK1 (0.40) MAPK1TSHRVCAM1PARP1ALDH1A1
SCHEMBL358730 0.78 MAPK1 (0.69) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL6125034 0.78 MAPK1 (0.63) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL29394047 0.78 MAPK1 (0.69) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL1665978 0.78 PARP1 (0.56) MAPK1TSHRPARP1ALDH1A1LMNA
SCHEMBL2149474 0.77 MAPK1 (0.61) MAPK1TSHRVCAM1ALDH1A1L3MBTL1
SCHEMBL306375 0.77 ALDH1A1 (0.64) MAPK1TSHRVCAM1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600725-B2 Selective GRP94 inhibitors and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2026-04-14 US disclosed
EP-3749325-B1 DREADD ACTUATORS US HEALTH (US) 2026-04-08 EP disclosed
US-11825744-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 US disclosed
US-11739063-B2 DREADD actuators THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-08-29 US disclosed
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230123747-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2023-04-20 US disclosed
CN-114057757-B Organic compound containing heterocyclic structure, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2022-12-16 CN disclosed
CN-115109070-A Compound containing indolo-heterocyclic structure and application thereof 烟台显华科技集团股份有限公司 2022-09-27 CN disclosed
US-11267816-B2 Selective Grp94 inhibitors and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2022-03-08 US disclosed
EP-0854867-B1 TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS GLAXO WELLCOME SPA (IT) 2002-07-31 EP disclosed
US-6037471-A FOR ELECTROCHROMIC MIRRORS FOR MOTOR VEHICLES GENTEX CORPORATION (US) 2000-03-14 US disclosed
US-6020987-A Electrochromic medium capable of producing a pre-selected color GENTEX CORPORATION (US) 2000-02-01 US disclosed
EP-0972227-A1 AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR GENTEX CORPORATION (US) 2000-01-19 EP disclosed
US-5998617-A MIXTURE OF ELECTROACTIVE MATERIALS AT PRESELECTIVE CONCENTRATION; GRAY COLOR GENTEX CORPORATION (US) 1999-12-07 US disclosed
US-5977136-A Tetrahydroquinolines as NMDA antagonists GLAXO WELLCOME SPA (IT) 1999-11-02 US disclosed
WO-1998044384-A1 AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR GENTEX CORPORATION (US) 1998-10-08 WO disclosed
EP-0854867-A1 TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS GLAXO WELLCOME S.p.A. (IT) 1998-07-29 EP disclosed
WO-1997012870-A1 TETRAHYDROQUINOLINES AS NMDA ANTAGONISTS GLAXO WELLCOME S.P.A. (IT) 1997-04-10 WO disclosed
US-5106407-A Algicides, funcilides, bactericides THE DOW CHEMICAL COMPANY (US) 1992-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739063-B2 DREADD actuators GRK1, GRK3, GRK2 MAPK1 1244/4885TSHR 255/4885VCAM1 3370/4885
US-11825744-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device PIEZO1, OCIAD1, AQP1 MAPK1 431/4885TSHR 4666/4885VCAM1 678/4885
US-11267816-B2 Selective Grp94 inhibitors and uses thereof HSP90B1, HSP90AB2P, HSPE1 MAPK1 2532/4885TSHR 3467/4885VCAM1 2562/4885
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF OCIAD1, OCIAD2, EPCAM MAPK1 3722/4885TSHR 4444/4885VCAM1 1724/4885
US-12600725-B2 Selective GRP94 inhibitors and uses thereof GRPR, HSPB1, HSP90AB2P MAPK1 2324/4885TSHR 454/4885VCAM1 4364/4885
US-20230123747-A1 SELECTIVE GRP94 INHIBITORS AND USES THEREOF HSP90B1, HSP90AB2P, HSPE1 MAPK1 2532/4885TSHR 3467/4885VCAM1 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.